248 related articles for article (PubMed ID: 19524575)
1. In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.
Besaratinia A; Kim SI; Hainaut P; Pfeifer GP
Gastroenterology; 2009 Sep; 137(3):1127-37, 1137.e1-5. PubMed ID: 19524575
[TBL] [Abstract][Full Text] [Related]
2. Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer.
Besaratinia A; Bates SE; Pfeifer GP
Cancer Res; 2002 Aug; 62(15):4331-8. PubMed ID: 12154037
[TBL] [Abstract][Full Text] [Related]
3. Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.
Woo LL; Egner PA; Belanger CL; Wattanawaraporn R; Trudel LJ; Croy RG; Groopman JD; Essigmann JM; Wogan GN; Bouhenguel JT
Toxicol Sci; 2011 Jul; 122(1):38-44. PubMed ID: 21507988
[TBL] [Abstract][Full Text] [Related]
4. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
5. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
6. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis.
Smela ME; Currier SS; Bailey EA; Essigmann JM
Carcinogenesis; 2001 Apr; 22(4):535-45. PubMed ID: 11285186
[TBL] [Abstract][Full Text] [Related]
7. Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells.
Besaratinia A; Pfeifer GP
Biochemistry; 2005 Jun; 44(23):8418-27. PubMed ID: 15938631
[TBL] [Abstract][Full Text] [Related]
8. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
9. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
10. Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.
Zhang W; He H; Zang M; Wu Q; Zhao H; Lu LL; Ma P; Zheng H; Wang N; Zhang Y; He S; Chen X; Wu Z; Wang X; Cai J; Liu Z; Sun Z; Zeng YX; Qu C; Jiao Y
Gastroenterology; 2017 Jul; 153(1):249-262.e2. PubMed ID: 28363643
[TBL] [Abstract][Full Text] [Related]
11. Differential mutagenicity of aflatoxin B1 in the liver of neonatal and adult mice.
Chen T; Heflich RH; Moore MM; Mei N
Environ Mol Mutagen; 2010 Mar; 51(2):156-63. PubMed ID: 19642212
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
Davies R; Gant TW; Smith LL; Styles JA
Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
Zhang YJ; Chen Y; Ahsan H; Lunn RM; Lee PH; Chen CJ; Santella RM
Int J Cancer; 2003 Feb; 103(4):440-4. PubMed ID: 12478658
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
Shen HM; Ong CN
Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
[TBL] [Abstract][Full Text] [Related]
15. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma.
Smela ME; Hamm ML; Henderson PT; Harris CM; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6655-60. PubMed ID: 12011430
[TBL] [Abstract][Full Text] [Related]
16. DNA polymerase ΞΆ limits chromosomal damage and promotes cell survival following aflatoxin exposure.
Lin YC; Owen N; Minko IG; Lange SS; Tomida J; Li L; Stone MP; Wood RD; McCullough AK; Lloyd RS
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13774-13779. PubMed ID: 27849610
[TBL] [Abstract][Full Text] [Related]
17. Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene.
Hulla JE; Chen ZY; Eaton DL
Cancer Res; 1993 Jan; 53(1):9-11. PubMed ID: 8380129
[TBL] [Abstract][Full Text] [Related]
18. Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
Paget V; Sichel F; Garon D; Lechevrel M
Mutat Res; 2008 Oct; 656(1-2):55-61. PubMed ID: 18725321
[TBL] [Abstract][Full Text] [Related]
19. Evidence that mutational activation of the ras genes may not be involved in aflatoxin B(1)-induced human hepatocarcinogenesis, based on sequence analysis of the ras and p53 genes.
Chao HK; Tsai TF; Lin CS; Su TS
Mol Carcinog; 1999 Oct; 26(2):69-73. PubMed ID: 10506750
[TBL] [Abstract][Full Text] [Related]
20. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
